Introduction and Acamprosate (TIP 49, Chapter 1 and Chapter 2)

From Incorporating Alcohol Pharmacotherapies Into Medical Practice (TIP 49)

About the Course:

Many health problems or mental disorders that healthcare practitioners (particularly those in primary care) encounter in their everyday practices derive from or are complicated by alcohol use disorders (AUDs). Consequently, healthcare practitioners are in key positions to manage the care of large numbers of individuals with AUDs. However, only a small percentage of these patients are actually treated for AUDs in these settings.

The U.S. Food and Drug Administration (FDA) has approved four medications to treat AUDs. These medications make treatment in primary care and other general medical settings a viable adjunct or alternative to specialty care, with many potential advantages. The consensus panel for this Treatment Improvement Protocol (TIP) believes that direct intervention by healthcare practitioners to treat AUDs is both possible and practical.

This TIP, Incorporating Alcohol Pharmacotherapies Into Medical Practice, discusses medications currently approved for treating alcohol use disorders (AUDs). It provides the basic information, evidence- and consensus-based guidelines, tools, and resources necessary to help health-care practitioners treat patients with AUDs.
Chapter 1 provides an overview of the use of medications to treat AUDs, and Chapter 2 presents detailed information about acamprosate.

Course materials are from Chapters 1 and 2, found on pages 1-14 of pdf document (pages 17 -30 if using Adobe toolbar page finder.) Course materials can be accessed either 1) online or 2) by ordering the publication free of charge from:


U.S. Department of Health and Human Services

Publication Date:



U.S. Department of Health and Human Services

Recommended For:

This course is recommended for health care professionals, especially addiction counselors, psychologists, mental health counselors, social workers, and nurses who seek knowledge about incorporating alcohol pharmacotherapies into medical practice. It is appropriate for all levels of participants’ knowledge.

Course Objectives:

  1. Discuss the presentation of alcohol use disorders in medical settings, recognition of alcohol dependence as a chronic illness, specialty treatment versus screening and brief intervention, and the rationale for using medications to treat alcohol dependence.

  2. Describe the development and pharmacology of acamprosate and the rationale for its use in the treatment of alcohol use disorders.

  3. Explain how acamprosate is used, which patients are appropriate to treat with acamprosate, and the duration and discontinuation of treatment.

Exam Questions

All exam questions for the course are visible on this page for members of Addiction Counselor CE.

Membership is free, and you can sign up today! You'll only pay when you're ready to purchase a course.

If you're already a member, please login to see the exam questions for this and all other courses.

Exam-related Actions

Categorized in:

Accepted By:

Login to automatically show approvals relevant to your state and discipline!
Use our CE Approvals tool to look up your state requirements and how Addiction Counselor CE can help you meet them.

Course Number: 101682
Total Credit Hours: 1cr
NBCC Credit Hours: 1cr
Exam Fee: $6.97
No Exam Fee with a Plus or Unlimited membership package! » More Info
Format: Online
4.38 out of 5
Popularity: 13 members have taken this course

Your Future Courses